Association between toxoplasmosis and autoimmune rheumatic diseases in Egyptian patients

• Published in: Reumatología clinica (Barcelona) Vol. 19; no. 9; pp. 488 - 494
• Main Authors: Aboukamar, Wafaa A., Habib, Samar, Tharwat, Samar, Nassar, Mohamed Kamal, Elzoheiry, Manal A., Atef, Rania, Elmehankar, Manar S.
• Format: Journal Article
• Language: English
• Published: 01.11.2023
• ISSN: 2173-5743; 2173-5743
• DOI: 10.1016/j.reumae.2023.03.006

PURPOSETo explore the association between T. gondii and autoimmune rheumatic diseases (ARDs).METHODSThis study involved 82 patients with ARDs: 44 rheumatoid arthritis (RA), 28 systemic lupus erythematosus (SLE), and 10 systemic sclerosis (SSc) and 61 age- and sex-matched controls. Sociodemographic, clinical, and laboratory data were collected, and disease activity was assessed. Exposure to toxoplasmosis risk factors was investigated. Serological tests for anti-Toxoplasma IgM and IgG antibodies were assessed using ELISA.RESULTSIn SLE patients, a significant difference of T. gondii IgM versus controls was detected (P=.03). In RA and SLE patients, T. gondii IgG showed a significant difference versus controls (34 (77.3%) P=.001 and 18 (64.3%) P=.03, respectively). There was no significant difference in SSc versus controls. Fetal congenital anomalies displayed a significant difference in IgM seropositive compared to seronegative patients (P=.04). Cat exposure showed a significant difference between IgM and IgG seropositive versus seronegative patients (12 (80.0%) P=.02 and 34 (59.6) P=.04, respectively). There was no significant difference in seropositive patients regarding history of abortion, neuro-psychiatric manifestations, disease activity parameters (ESR, CRP), or different regimens of medications.CONCLUSIONToxoplasma IgM seropositivity is associated with SLE patients. T. gondii IgG seropositivity is associated with both RA and SLE patients. However, Toxoplasma seropositivity had no association with SSc patients. An association between fetal congenital anomalies and IgM seropositivity was demonstrated. A linkage between cat exposure as a risk factor and toxoplasmosis was suggested among ARD patiants. Exploration of impact of toxoplasmosis on ARDs is a necessity through randomized controlled trials.